This week on Contemporary OB/GYN®: Oct. 18 to Oct. 22
Here's what to look for this week on Contemporary OB/GYN®.
This week's topics include:
Diagnosing and treating vaginal discharge
Moderna, Johnson and Johnson COVID-19 boosters recommended by FDA
The advisory panel is also scheduled to discuss Merck antiviral pill late next month.
Changes in menstrual cycle length could signal increased risk of atherosclerosis
Using data from SWAN DHS, investigators determined changes in menstrual cycle length prior to a woman's final menstrual period were associated with changes in carotid intima-media thickness and brachial-ankle pulse wave velocity.
Combined contraceptive pills may reduce risk of diabetes in PCOS
A pair of studies provide insight into the increased risk of dysglycemia among women with PCOS and the potential influence of combined oral contraceptive pills on this risk in a population-based cohort.
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
Unraveling preeclampsia: Insights into heterogeneity and intravascular inflammation
April 22nd 2024A recent study delved into the intricate clusters of term preeclampsia, shedding light on its diverse manifestations and the pivotal role of intravascular inflammation, paving the way for improved classification and management strategies.
Read More
